Simplify Volatility Premium ETF's management has successfully navigated a VIX spike in August with sustainable 15%+ distributions. See why I rate SVOL a buy.

ClearBridge Investments, an investment management company, released its “ClearBridge SMID Cap Growth Strategy” second quarter ...

Kiran Mazumdar-Shaw accompanied her niece in ringing the opening bell at the Nasdaq headquarters in New York City, marking a ...

Hong Kong could potentially climb back into the top three among global initial public offering (IPO) markets by the end of the year, as analysts believe the recent bull run is set to attract some ...

Claire Mazumdar, CEO of Bicara Therapeutics and niece of Kiran Mazumdar-Shaw, led her company to a successful Nasdaq debut, ...

We recently compiled a list of the 10 Best Most Active Stocks To Invest In Now. In this article, we are going to take a look ...

Shaw's niece Claire Mazumdar's company Bicara Therapeutics made its debut at Nasdaq. For the ringing of the opening bell at ...

By Arasu Kannagi Basil and Prakhar Srivastava (Reuters) -Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

FBS Global Limited FBGL IPO will take place September, 27 on the NASDAQ exchange under the ticker FBGL. The company is ...

The acquisition of Adenza is expected to significantly boost Nasdaq's software revenue mix. Read why I maintain my strong buy ...